A closer look into the IBSA world: IBSA Germany

A closer look into the IBSA World is the series dedicated to discovering IBSA’s subsidiaries. With this news cycle we aim to offer an overview of the initiatives and challenges undertaken by IBSA’s subsidiaries in local contexts, highlighting the diversity and reach of their operations at international level. Today’s in-depth analysis is dedicated to IBSA Germany.

Founded in June 2023, thanks to the acquisition of Marckyrl Pharma GmbH, a German pharmaceutical company specialising in gynaecology and fertility, and historic distributor of IBSA products in that country, IBSA Germany is one of the youngest subsidiaries of the IBSA Group. Marion Bock, General Manager of IBSA Germany, tells us how this acquisition has represented a turning point for the expansion of IBSA into one of the main European markets.

“Our subsidiary was created with the determination to become a reference point in the German pharmaceutical market. Thanks to a strong and courageous team, we are building the future of IBSA in Germany, focusing on quality and authentic relationships with our customers”.

Germany is known for its organisation and a work culture that favours precision and efficiency. It is not surprising, therefore, that the creation of IBSA Germany was accompanied by a profound organisational restructuring.

The new headquarters was moved to Düsseldorf, a strategic city for several cosmetic and pharmaceutical businesses. In December 2024, the IBSA Germany team – which was also created almost entirely from scratch – will number as many as 44 people.

TOWARDS A NEW EXPANSION

IBSA Germany’s strategy is inspired by the “humanised business vision” very dear to IBSA’s President Arturo Licenziati, and is based on three key principles: entrepreneurial spirit, empathy and energy. Currently, the subsidiary is active in four therapeutic areas: reproductive medicine, endocrinology and aesthetic and osteoarticular medicine.

One of the main challenges was the introduction of new products into the German market. Adapting to the stringent local regulations and aligning corporate standards with the expectations of the local market – which required plenty of interaction with healthcare professionals – was crucial.

Another key objective was the reorganisation of the product portfolio in the areas of aesthetic and osteoarticular medicine. This involved a strategic management of relationships with stakeholders, as well as a constant communication with the medical community, complemented by a marketing strategy based on quality scientific content.

TEAM SPIRIT AND SUSTAINABILITY

IBSA Germany promotes an open and inclusive corporate culture, reflecting the diversity and integration of German society. “In Germany we are used to cultural and social inclusion, which is also reflected within our company”, said Bock, underlining the importance of living this professional and human experience in an environment that places the value of the Person at the centre.

In terms of sustainability, the subsidiary adopts responsible working practices aimed at reducing environmental impact, such as promoting the use of public transport for work travel and operating in offices designed to reduce energy consumption and optimise resources. Thus, despite its recent creation, IBSA Germany has already shown a decisive character and strong determination and professionalism, standing out for a concrete and human approach to business.